Your search for hypertension returned 1996 results

Investigators assessed the efficacy and safety of pulmonary vasodilators to treat pediatric pulmonary arterial hypertension.

Blood pressure values less than 140/90mmHg tied to increased mortality risk for octogenarians

The Food and Drug Administration (FDA) has approved Rocklatan (netarsudil 0.02% and latanoprost 0.005% ophthalmic solution; Aerie) for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

In the latest evidence-based guideline from the American College of Chest Physicians, published online January 17 in CHEST.

Psoriasis is associated with an increased risk for cardiovascular interventions in patients with hypertension, according to a new study.

Previous studies on the suitability of diuretics for patients with hypertension and diabetes reveal inconsistencies.

Losartan Potassium and Hydrochlorothiazide Tablets are approved to treat hypertension, alone or in combination with other antihypertensive drugs.

The researchers found that the regression-derived thresholds for home BP corresponding to clinic BP for stage 1 hypertension were 129/80, 130/80, and 126/78mmHg for blacks, whites, and Hispanics, respectively, among untreated participants.

Recent data suggest that the endothelin receptor antagonist macitentan can be used to target the endothelin pathway in patients with portopulmonary hypertension.

Xelpros contains latanoprost, a prostaglandin F2α analogue that is believed to reduce IOP by increasing the outflow of aqueous humor.